DK0686637T3 - Tetracykliske 1,4-oxazinderivater, fremgangsmåde til fremstilling deraf og farmaceutiske tilberedninger, der indeholder dis - Google Patents
Tetracykliske 1,4-oxazinderivater, fremgangsmåde til fremstilling deraf og farmaceutiske tilberedninger, der indeholder disInfo
- Publication number
- DK0686637T3 DK0686637T3 DK95401311T DK95401311T DK0686637T3 DK 0686637 T3 DK0686637 T3 DK 0686637T3 DK 95401311 T DK95401311 T DK 95401311T DK 95401311 T DK95401311 T DK 95401311T DK 0686637 T3 DK0686637 T3 DK 0686637T3
- Authority
- DK
- Denmark
- Prior art keywords
- tetracyclic
- processes
- preparation
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9406985A FR2721027B1 (fr) | 1994-06-08 | 1994-06-08 | Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0686637T3 true DK0686637T3 (da) | 2000-09-18 |
Family
ID=9463983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95401311T DK0686637T3 (da) | 1994-06-08 | 1995-06-07 | Tetracykliske 1,4-oxazinderivater, fremgangsmåde til fremstilling deraf og farmaceutiske tilberedninger, der indeholder dis |
Country Status (17)
Country | Link |
---|---|
US (2) | US5593989A (de) |
EP (1) | EP0686637B1 (de) |
JP (1) | JP3157418B2 (de) |
CN (1) | CN1050358C (de) |
AT (1) | ATE192155T1 (de) |
AU (1) | AU681780B2 (de) |
CA (1) | CA2151096C (de) |
DE (1) | DE69516457T2 (de) |
DK (1) | DK0686637T3 (de) |
ES (1) | ES2147825T3 (de) |
FI (1) | FI111948B (de) |
FR (1) | FR2721027B1 (de) |
GR (1) | GR3033762T3 (de) |
NO (1) | NO304741B1 (de) |
NZ (1) | NZ272298A (de) |
PT (1) | PT686637E (de) |
ZA (1) | ZA954738B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2741074B1 (fr) * | 1995-11-09 | 1997-12-19 | Adir | Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
EP0988289A2 (de) * | 1997-06-05 | 2000-03-29 | Takeda Pharmaceutical Company Limited | Benzofurane und benzothiophene als unterdrücker der neurodegeneration |
EP1615906A1 (de) * | 2003-04-03 | 2006-01-18 | Vertex Pharmaceuticals Incorporated | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen |
FR2906249B1 (fr) * | 2006-09-26 | 2008-12-19 | Servier Lab | Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1204745A (en) * | 1981-11-20 | 1986-05-20 | Merck Co. | Hexahydronaphth (1,2-b) -1,4 -oxazines |
US4420480A (en) * | 1981-11-20 | 1983-12-13 | Merck & Co., Inc. | Hexahydronaphth[1,2-b]-1,4-oxazines |
US4435231A (en) * | 1982-03-31 | 1984-03-06 | The United States Of America As Represented By The United States Department Of Energy | Cold worked ferritic alloys and components |
DE3583307D1 (en) | 1984-05-10 | 1991-08-01 | Ciba Geigy Ag | Benzo-(pyrano und thiopyrano)-pyridine. |
US4774243A (en) * | 1985-12-24 | 1988-09-27 | Merck & Co., Inc. | Dopamine agonists for treating elevated intraocular pressure |
US4792548A (en) * | 1986-05-21 | 1988-12-20 | Warner-Lambert Company | Trans-benzopyran-(4,3-b)-1,4-oxazine derivatives, intermediates and pharmaceutical use |
US5294618A (en) * | 1989-07-28 | 1994-03-15 | Merck Sharp & Dohme Limited | Octahydrobenzisoquinoline derivatives as antipsychotic agents |
WO1993024471A1 (en) | 1992-06-02 | 1993-12-09 | Whitby Research, Inc. | Substituted naphthoxazines useful as dopaminergics |
-
1994
- 1994-06-08 FR FR9406985A patent/FR2721027B1/fr not_active Expired - Lifetime
-
1995
- 1995-06-01 US US08/456,504 patent/US5593989A/en not_active Expired - Fee Related
- 1995-06-06 AU AU20523/95A patent/AU681780B2/en not_active Ceased
- 1995-06-06 CA CA002151096A patent/CA2151096C/fr not_active Expired - Fee Related
- 1995-06-07 FI FI952802A patent/FI111948B/fi not_active IP Right Cessation
- 1995-06-07 DK DK95401311T patent/DK0686637T3/da active
- 1995-06-07 DE DE69516457T patent/DE69516457T2/de not_active Expired - Fee Related
- 1995-06-07 PT PT95401311T patent/PT686637E/pt unknown
- 1995-06-07 AT AT95401311T patent/ATE192155T1/de not_active IP Right Cessation
- 1995-06-07 ES ES95401311T patent/ES2147825T3/es not_active Expired - Lifetime
- 1995-06-07 NZ NZ272298A patent/NZ272298A/en unknown
- 1995-06-07 EP EP95401311A patent/EP0686637B1/de not_active Expired - Lifetime
- 1995-06-07 NO NO952249A patent/NO304741B1/no not_active IP Right Cessation
- 1995-06-07 CN CN95107344A patent/CN1050358C/zh not_active Expired - Fee Related
- 1995-06-08 ZA ZA954738A patent/ZA954738B/xx unknown
- 1995-06-08 JP JP14177295A patent/JP3157418B2/ja not_active Expired - Fee Related
-
1996
- 1996-06-06 US US08/659,267 patent/US5668142A/en not_active Expired - Fee Related
-
2000
- 2000-06-23 GR GR20000401458T patent/GR3033762T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2151096A1 (fr) | 1995-12-09 |
CN1050358C (zh) | 2000-03-15 |
NO952249L (no) | 1995-12-11 |
GR3033762T3 (en) | 2000-10-31 |
ATE192155T1 (de) | 2000-05-15 |
ES2147825T3 (es) | 2000-10-01 |
FR2721027A1 (fr) | 1995-12-15 |
US5593989A (en) | 1997-01-14 |
CA2151096C (fr) | 2003-07-08 |
FI952802A (fi) | 1995-12-09 |
EP0686637A1 (de) | 1995-12-13 |
CN1120541A (zh) | 1996-04-17 |
AU681780B2 (en) | 1997-09-04 |
EP0686637B1 (de) | 2000-04-26 |
AU2052395A (en) | 1995-12-14 |
FI111948B (fi) | 2003-10-15 |
JP3157418B2 (ja) | 2001-04-16 |
NZ272298A (en) | 1996-05-28 |
NO952249D0 (no) | 1995-06-07 |
FI952802A0 (fi) | 1995-06-07 |
US5668142A (en) | 1997-09-16 |
PT686637E (pt) | 2000-08-31 |
NO304741B1 (no) | 1999-02-08 |
JPH07330778A (ja) | 1995-12-19 |
FR2721027B1 (fr) | 1996-07-19 |
DE69516457T2 (de) | 2001-01-18 |
DE69516457D1 (de) | 2000-05-31 |
ZA954738B (en) | 1996-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2061465T3 (es) | Derivados de oxadiazolilalquilpurina, su preparacion y su aplicacion en productos farmaceuticos. | |
DK0686637T3 (da) | Tetracykliske 1,4-oxazinderivater, fremgangsmåde til fremstilling deraf og farmaceutiske tilberedninger, der indeholder dis | |
ATE102210T1 (de) | 1h,3h,7-pyrrolo (1,2-c>thiazolcarbonsaeureamidderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
DK0717036T3 (da) | Anvendelse af 5-acyl-1,4-dihydropyridiner til bekæmpelse af sygdomme i CNS | |
IL59128A0 (en) | Pyrimido- and imidazo-pyridoindole derivatives,their preparation and pharmaceutical compositions containing them | |
DK148288A (da) | N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne | |
DK0446921T3 (da) | Optisk aktive alkylendioxybenzenderivater og deres anvendelse ved terapi | |
DK0672043T3 (da) | Hidtil ukendte 4-(3-benzofuranyl)-piperidinyl- og 4-(3-benzothienyl)-piperidinyl-derivater og farmaceutiske præparater indeholdende dem | |
DE69611594T2 (de) | Tetrazyclische 1,4-Oxazinverbindungen, Verfahren zu ihrer Herstellung und dieseenthaltende pharmazeutische Zubereitungen | |
DK0899267T3 (da) | Disubstituerede trans-3,4,4a,5,6,10b-hexahydro-2H-napht[1,2-b]-1,4-oxiner, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende disse | |
FI810103L (fi) | Nya 2,3-dihydro-imidazo /1,2-b/ pyridazinderivat foerfarande foer deras framstaellning och deras terapeutiska anvaendning | |
ATE29877T1 (de) | Mittel zur senkung der herzfrequenz. | |
DK0586344T3 (da) | Oxazolidinforbindelser og deres anvendelse som lægemidler | |
ES8603846A1 (es) | Procedimiento de preparacion de nuevos derivados a-etilami- noetoxibencilalcoholicos con un grupo fenil sustituido en situacion a y de sus sales de adicion acidas y amonicas cua-ternarias | |
NO972942D0 (no) | 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse | |
SE8104508L (sv) | Ergolinderivat, sett att framstella dessa, farmaceutiska kompositioner innehallande desamma och anvendning derav vid terapeutisk behandling | |
ES2158055T3 (es) | Nuevas amino-alquil-benzotiazolinonas, su procedimiento de preparacio n y las composiciones farmaceuticas que las contienen. | |
ES8604099A1 (es) | Un procedimiento de preparar un derivado de n-acil-amino- acido |